These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 14751165)

  • 21. Stage II uterine papillary serous carcinoma: Carboplatin/paclitaxel chemotherapy improves recurrence and survival outcomes.
    Fader AN; Nagel C; Axtell AE; Zanotti KM; Kelley JL; Moore KN; Secord AA; Walsh CS; Huh WK; Gehrig PA; Gibbons H; Rose PG; Havrilesky LJ; Tuller E; Drake RD; Bottsford-Miller J; O'Malley DM;
    Gynecol Oncol; 2009 Mar; 112(3):558-62. PubMed ID: 19118888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Uterine Papillary Serous Carcinoma: A Single-Institution Review of 62 Cases.
    Black C; Feng A; Bittinger S; Quinn M; Neesham D; McNally O
    Int J Gynecol Cancer; 2016 Jan; 26(1):133-40. PubMed ID: 26588230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival advantage associated with multimodal therapy in women with node-positive (stage-IIIC) uterine papillary serous carcinoma: a National Cancer Database study.
    Lin JF; Muñiz K; Sukumvanich P; Gehrig P; Beriwal S; Kelley JL; Edwards RP; Olawaiye AB
    BJOG; 2016 Oct; 123(11):1846-52. PubMed ID: 26537059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Irradiation alone or combined with surgery in stage IB, IIA, and IIB carcinoma of uterine cervix: update of a nonrandomized comparison.
    Perez CA; Grigsby PW; Camel HM; Galakatos AE; Mutch D; Lockett MA
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):703-16. PubMed ID: 7860381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN).
    Goldberg H; Miller RC; Abdah-Bortnyak R; Steiner M; Yildiz F; Meirovitz A; Villà S; Poortmans PM; Azria D; Zidan J; Ozsahin M; Abacioglu U; Gold DG; Amit A; Lavie O; Atahan IL; Kuten A;
    Gynecol Oncol; 2008 Feb; 108(2):298-305. PubMed ID: 18096209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Uterine Clear Cell Carcinoma: Does Adjuvant Chemotherapy Improve Outcomes?
    Nguyen JM; Bouchard-Fortier G; Bernardini MQ; Atenafu EG; Han G; Vicus D; Ferguson SE; Gien LT
    Int J Gynecol Cancer; 2017 Jan; 27(1):69-76. PubMed ID: 27668398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival impact of cytoreduction to microscopic disease for advanced stage cancer of the uterine corpus: a retrospective cohort study.
    Alagkiozidis I; Grossman A; Tang NZ; Weedon J; Mize B; Salame G; Lee YC; Abulafia O
    Int J Surg; 2015 Feb; 14():61-6. PubMed ID: 25576762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I-IV carcinosarcoma (CS) of the uterus.
    Wolfson AH; Brady MF; Rocereto T; Mannel RS; Lee YC; Futoran RJ; Cohn DE; Ioffe OB
    Gynecol Oncol; 2007 Nov; 107(2):177-85. PubMed ID: 17822748
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of adjuvant chemotherapy versus whole abdominopelvic radiation on the survival of patients with advanced stage uterine papillary serous carcinoma.
    Hamilton CA; Cheung MK; Osann K; Balzer B; Berman ML; Husain A; Teng NN; Kapp DS; Chan JK
    Gynecol Oncol; 2006 Nov; 103(2):679-83. PubMed ID: 16793126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer.
    Winter-Roach BA; Kitchener HC; Dickinson HO
    Cochrane Database Syst Rev; 2009 Jan; (1):CD004706. PubMed ID: 19160239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of adjuvant therapy in stage IA serous and clear cell uterine cancer: A multi-institutional pooled analysis.
    Qu XM; Velker VM; Leung E; Kwon JS; Elshaikh MA; Kong I; Logie NA; Mendez LC; van der Putten LJ; Donovan EK; Munkarah AR; Wiebe EM; Parra-Herran C; Warner A; Louie AV; D'Souza DP
    Gynecol Oncol; 2018 May; 149(2):283-290. PubMed ID: 29544706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer.
    Alvarez Secord A; Havrilesky LJ; Bae-Jump V; Chin J; Calingaert B; Bland A; Rutledge TL; Berchuck A; Clarke-Pearson DL; Gehrig PA
    Gynecol Oncol; 2007 Nov; 107(2):285-91. PubMed ID: 17688923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment outcomes in completely resected stage I to stage IV uterine carcinosarcoma with rhabdomyosarcoma differentiation.
    Makker V; Kravetz SJ; Gallagher J; Orodel OP; Zhou Q; Iasonos A; DeLair D; Aghajanian C; Hensley ML
    Int J Gynecol Cancer; 2013 Nov; 23(9):1635-41. PubMed ID: 24172099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of optimal debulking in advanced stage serous carcinoma of the uterus.
    Moller KA; Gehrig PA; Van Le L; Secord AA; Schorge J
    Gynecol Oncol; 2004 Jul; 94(1):170-4. PubMed ID: 15262137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcome and pattern of failure in pathologic stage I-II papillary serous carcinoma of the endometrium: implications for adjuvant radiation therapy.
    Mehta N; Yamada SD; Rotmensch J; Mundt AJ
    Int J Radiat Oncol Biol Phys; 2003 Nov; 57(4):1004-9. PubMed ID: 14575831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The efficacy of adjuvant platinum-based chemotherapy in Stage I uterine papillary serous carcinoma (UPSC).
    Dietrich CS; Modesitt SC; DePriest PD; Ueland FR; Wilder J; Reedy MB; Pavlik EJ; Kryscio R; Cibull M; Giesler J; Manahan K; Huh W; Cohn D; Powell M; Slomovitz B; Higgins RV; Merritt W; Hunter J; Puls L; Gehrig P; van Nagell JR
    Gynecol Oncol; 2005 Dec; 99(3):557-63. PubMed ID: 16154185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of adjuvant radiation therapy in patients with intermediate-risk Stages IC and II uterine corpus cancer: a patient care evaluation study from the American College of Surgeons National Cancer Data Base.
    Straughn JM; Numnum TM; Kilgore LC; Partridge EE; Phillips JL; Markman M; Thomas GM; Burke TW;
    Gynecol Oncol; 2005 Dec; 99(3):530-5. PubMed ID: 16198401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Population-based treatment and outcomes of Stage I uterine serous carcinoma.
    van der Putten LJ; Hoskins P; Tinker A; Lim P; Aquino-Parsons C; Kwon JS
    Gynecol Oncol; 2014 Jan; 132(1):61-4. PubMed ID: 24219983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of patients with lymphomas of the uterus or cervix with combination chemotherapy and radiation therapy.
    Stroh EL; Besa PC; Cox JD; Fuller LM; Cabanillas FF
    Cancer; 1995 May; 75(9):2392-9. PubMed ID: 7712450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaginal brachytherapy for early-stage carcinosarcoma of the uterus.
    Brown LC; Petersen IA; Haddock MG; Bakkum-Gamez JN; Lee LJ; Cimbak NC; Berkowitz RS; Viswanathan AN
    Brachytherapy; 2015; 14(4):433-9. PubMed ID: 25890795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.